AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 6697024 — intervention group
Group type: EXPERIMENTAL
Intervention: In vivo exposure (2 sessions)
Number of subjects: 64
Study 6697024 — intervention group
Group type: EXPERIMENTAL
Intervention: Imaginal exposure (2 sessions)
Number of subjects: 64
Study 6697024 — intervention group
Group type: EXPERIMENTAL
Intervention: Imaginal followed by in vivo exposure (2 sessions)
Number of subjects: 64
Study 6697024 — intervention group
Group type: EXPERIMENTAL
Intervention: In vivo followed by imaginal exposure (2 sessions)
Number of subjects: 64
Study 6697024 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypothesized cues
Number of subjects: 64
Study 31780009 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided yoga
Number of subjects: 18
Study 31780009 — intervention group
Group type: COMPARATOR
Intervention: Light stretching protocol
Number of subjects: 18
Study 28803345 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical anterior discectomy procedure for cervical single level degenerative disc disease
Number of subjects: 0
Study 27018174 — intervention group
Group type: EXPERIMENTAL
Intervention: CPAP + ME
Number of subjects: 83
Study 27018174 — intervention group
Group type: COMPARATOR
Intervention: CPAP only
Number of subjects: 83
Study 25257871 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhalation of 15 mg of terbutaline (TER)
Number of subjects: 9
Study 25257871 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 9
Study 22486552 — intervention group
Group type: EXPERIMENTAL
Intervention: Pantoprazole treatment for up to 16 weeks
Number of subjects: 626
Study 22486552 — intervention group
Group type: COMPARATOR
Intervention: Observational phase after pantoprazole treatment
Number of subjects: 626
Study 20828102 — intervention group
Group type: EXPERIMENTAL
Intervention: Four session brief motivational intervention encouraging organ donation
Number of subjects: 2789
Study 20828102 — intervention group
Group type: COMPARATOR
Intervention: Four session stylist-delivered health education program (comparison)
Number of subjects: 2789
Study 17094978 — intervention group
Group type: EXPERIMENTAL
Intervention: Mifepristone (25 mg, two pills every 14 days during DMPA therapy)
Number of subjects: 50
Study 17094978 — intervention group
Group type: COMPARATOR
Intervention: Placebo (two pills every 14 days during DMPA therapy)
Number of subjects: 50
Study 17848882 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25 mL Epaxal
Number of subjects: 308
Study 17848882 — intervention group
Group type: COMPARATOR
Intervention: 0.5 mL Epaxal
Number of subjects: 308
Study 17848882 — intervention group
Group type: COMPARATOR
Intervention: Havrix Junior
Number of subjects: 308
Study 17848882 — intervention group
Group type: COMPARATOR
Intervention: Local injection site pain
Number of subjects: 308
Study 15024364 — intervention group
Group type: EXPERIMENTAL
Intervention: NaOCl irrigation with cold lateral condensation (CLC)
Number of subjects: 40
Study 15024364 — intervention group
Group type: EXPERIMENTAL
Intervention: NaOCl irrigation with warm vertical condensation (WVC)
Number of subjects: 40
Study 15024364 — intervention group
Group type: EXPERIMENTAL
Intervention: NaOCl+EDTA irrigation with cold lateral condensation (CLC)
Number of subjects: 40
Study 15024364 — intervention group
Group type: EXPERIMENTAL
Intervention: NaOCl+EDTA irrigation with warm vertical condensation (WVC)
Number of subjects: 40
Study 15024364 — intervention group
Group type: COMPARATOR
Intervention: All groups
Number of subjects: 40
Study 11232181 — intervention group
Group type: EXPERIMENTAL
Intervention: Transjugular intrahepatic portosystemic shunts (TIPS)
Number of subjects: 0
Study 9010709 — intervention group
Group type: EXPERIMENTAL
Intervention: Sauna bathing session (temperature 85-100 degrees C, relative humidity 25-30%)
Number of subjects: 6
Study 9010709 — intervention group
Group type: COMPARATOR
Intervention: Control session
Number of subjects: 6
Study 9010709 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous midazolam (0.05 mg.kg-1)
Number of subjects: 6
Study 1596551 — intervention group
Group type: EXPERIMENTAL
Intervention: Gd-BOPTA (0.05-0.1 mmol/kg body weight)
Number of subjects: 8
Study 6529913 — intervention group
Group type: EXPERIMENTAL
Intervention: Trazodone (223 mg daily)
Number of subjects: 14
Study 6529913 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline (95.3 mg daily)
Number of subjects: 14
Study 6529913 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 31409112 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical trial evidence of a 'medication'
Number of subjects: 476
Study 31409112 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical trial evidence of a 'topical steroid'
Number of subjects: 476
Study 31409112 — intervention group
Group type: EXPERIMENTAL
Intervention: Anecdote of a 'medication'
Number of subjects: 476
Study 31409112 — intervention group
Group type: EXPERIMENTAL
Intervention: Anecdote of a 'topical steroid'
Number of subjects: 476
Study 31409112 — intervention group
Group type: EXPERIMENTAL
Intervention: Both clinical trial evidence and anecdote of a 'medication'
Number of subjects: 476
Study 31409112 — intervention group
Group type: EXPERIMENTAL
Intervention: Both clinical trial evidence and anecdote of a 'topical steroid'
Number of subjects: 476
Study 31409112 — intervention group
Group type: EXPERIMENTAL
Intervention: Doctor's recommendation
Number of subjects: 476
Study 31409112 — intervention group
Group type: COMPARATOR
Intervention: No safety information provided
Number of subjects: 476
Study 31067223 — intervention group
Group type: EXPERIMENTAL
Intervention: 18-week supervised moderate-to-high intensity aerobic and resistance exercise program (two 1-hour sessions/week)
Number of subjects: 92
Study 31067223 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Number of subjects: 92
Study 31067223 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity aerobic exercise (cycling at the ventilatory threshold)
Number of subjects: 92
Study 31067223 — intervention group
Group type: EXPERIMENTAL
Intervention: Muscle strength exercises
Number of subjects: 92
Study 31067223 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise advice
Number of subjects: 92
Study 28971804 — intervention group
Group type: EXPERIMENTAL
Intervention: Truview PCD
Number of subjects: 150
Study 28971804 — intervention group
Group type: EXPERIMENTAL
Intervention: C-MAC
Number of subjects: 150
Study 28971804 — intervention group
Group type: COMPARATOR
Intervention: Macintosh
Number of subjects: 150
Study 25353684 — intervention group
Group type: EXPERIMENTAL
Intervention: MD + EVOO (n = 41)
Number of subjects: 98
Study 25353684 — intervention group
Group type: EXPERIMENTAL
Intervention: MD + Nuts (n = 27)
Number of subjects: 98
Study 25353684 — intervention group
Group type: COMPARATOR
Intervention: LFD (n = 30)
Number of subjects: 98
Study 23768224 — intervention group
Group type: EXPERIMENTAL
Intervention: Gain-framed messages
Number of subjects: 64
Study 23768224 — intervention group
Group type: COMPARATOR
Intervention: Loss-framed messages
Number of subjects: 64
Study 21939467 — intervention group
Group type: EXPERIMENTAL
Intervention: DBS + Optimal Drug Therapy (ODT)
Number of subjects: 30
Study 21939467 — intervention group
Group type: COMPARATOR
Intervention: Optimal Drug Therapy (ODT)
Number of subjects: 30
Study 19491396 — intervention group
Group type: EXPERIMENTAL
Intervention: Auditory cues
Number of subjects: 133
Study 19491396 — intervention group
Group type: COMPARATOR
Intervention: Visual cues
Number of subjects: 133
Study 19491396 — intervention group
Group type: COMPARATOR
Intervention: Somatosensory cues
Number of subjects: 133
Study 19491396 — intervention group
Group type: COMPARATOR
Intervention: No cues
Number of subjects: 133
Study 16931693 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical Stimulation (ES) technique
Number of subjects: 218
Study 16931693 — intervention group
Group type: COMPARATOR
Intervention: Mechanical Paresthesia (MP) technique
Number of subjects: 218
Study 16931693 — intervention group
Group type: EXPERIMENTAL
Intervention: Both techniques
Number of subjects: 218
Study 14622048 — intervention group
Group type: EXPERIMENTAL
Intervention: Template Theory (TT)
Number of subjects: 36
Study 14622048 — intervention group
Group type: EXPERIMENTAL
Intervention: Constraint Attunement Hypothesis (CAH)
Number of subjects: 36
Study 11113398 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise (3 sessions/week for 2 years)
Number of subjects: 123
Study 11113398 — intervention group
Group type: COMPARATOR
Intervention: Non-exercise (control group)
Number of subjects: 123
Study 11113398 — intervention group
Group type: COMPARATOR
Intervention: Oral contraceptive use
Number of subjects: 123
Study 9036412 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy treatment according to the protocol of the German AML‐Cooperative Group (Münster, FRG)
Number of subjects: 61
Study 9036412 — intervention group
Group type: EXPERIMENTAL
Intervention: Inpatient treatment
Number of subjects: 61
Study 9036412 — intervention group
Group type: EXPERIMENTAL
Intervention: Antileukemic therapy
Number of subjects: 61
Study 1545464 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone care (clinician-initiated telephone calls, double the recommended interval for face-to-face follow-up, three intervening telephone contacts)
Number of subjects: 497
Study 1545464 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group, unchanged follow-up interval)
Number of subjects: 497
Study 1545464 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone care for subgroup of patients with fair or poor overall health (n = 180)
Number of subjects: 497
Study 4043711 — intervention group
Group type: EXPERIMENTAL
Intervention: 9-deoxy-16, 16-dimethyl-9-methylene prostaglandin E2 (vaginal suppository)
Number of subjects: 38
Study 4043711 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study 30802185 — intervention group
Group type: EXPERIMENTAL
Intervention: Disease management program intervention group (n=156)
Number of subjects: 321
Study 30802185 — intervention group
Group type: COMPARATOR
Intervention: Usual care group (n=165)
Number of subjects: 321
Study 29924040 — intervention group
Group type: EXPERIMENTAL
Intervention: Posterior paraspinal muscle approach (PPMA)
Number of subjects: 62
Study 29924040 — intervention group
Group type: COMPARATOR
Intervention: Post-middle approach (PA)
Number of subjects: 62
Study 27552848 — intervention group
Group type: EXPERIMENTAL
Intervention: Levetiracetam (LEV)
Number of subjects: 308
Study 27552848 — intervention group
Group type: COMPARATOR
Intervention: Standard AEDs (VPA-ER, CBZ-CR)
Number of subjects: 308
Study 27552848 — intervention group
Group type: COMPARATOR
Intervention: VPA-ER
Number of subjects: 308
Study 27552848 — intervention group
Group type: COMPARATOR
Intervention: CBZ-CR
Number of subjects: 308
Study 24170677 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic anthocyanin consumption (500 mg/day)
Number of subjects: 0
Study 24170677 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute anthocyanin consumption (single bolus)
Number of subjects: 0
Study 24170677 — intervention group
Group type: COMPARATOR
Intervention: Chronic vs Acute exposure
Number of subjects: 0
Study 22771848 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin 80 mg daily for 8 weeks
Number of subjects: 24
Study 22771848 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 8 weeks
Number of subjects: 24
Study 21145519 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive electrical stimulation (ES) for 1 hour over the quadriceps 5 days per week for 6 weeks
Number of subjects: 26
Study 21145519 — intervention group
Group type: COMPARATOR
Intervention: Usual rehabilitative care
Number of subjects: 26
Study 21145519 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive electrical stimulation (ES)
Number of subjects: 26
Study 17387192 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral sildenafil (0.3 mg x kg(‐1), every 3 hours for 24‐48 hours)
Number of subjects: 22
Study 17387192 — intervention group
Group type: COMPARATOR
Intervention: Control group (no sildenafil)
Number of subjects: 22
Study 16261199 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human interferon alpha‐2b for nasal spray
Number of subjects: 0
Study 16261199 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 11345492 — intervention group
Group type: EXPERIMENTAL
Intervention: Close reach position
Number of subjects: 20
Study 11345492 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher step
Number of subjects: 20
Study 11345492 — intervention group
Group type: COMPARATOR
Intervention: Far reach position
Number of subjects: 20
Study 11345492 — intervention group
Group type: COMPARATOR
Intervention: Lower step
Number of subjects: 20
Study 9724114 — intervention group
Group type: EXPERIMENTAL
Intervention: Cigarette smoking
Number of subjects: 3500
Study 8605504 — intervention group
Group type: EXPERIMENTAL
Intervention: Placement of dense non‐resorbable hydroxyapatite granules into fresh canine sockets at the time of immediate denture provision
Number of subjects: 35
Study 8605504 — intervention group
Group type: COMPARATOR
Intervention: Control group (no hydroxyapatite granules)
Number of subjects: 35
Study 2751788 — intervention group
Group type: EXPERIMENTAL
Intervention: Conducting a brief sexual history interview with a community volunteer
Number of subjects: 0
Study 2751788 — intervention group
Group type: EXPERIMENTAL
Intervention: Observing a brief sexual history interview
Number of subjects: 0
Study 2751788 — intervention group
Group type: COMPARATOR
Intervention: No experience taking a sexual history
Number of subjects: 0
Study 30672253 — intervention group
Group type: COMPARATOR
Intervention: Warm acupuncture (Jianzhen (SI 9), Jianyu (LI 15), Jianliao (TE 14), etc.)
Number of subjects: 90
Study 30672253 — intervention group
Group type: COMPARATOR
Intervention: Yoga posture method
Number of subjects: 90
Study 30672253 — intervention group
Group type: EXPERIMENTAL
Intervention: Warm acupuncture combined with yoga posture method
Number of subjects: 90
Study 29117180 — intervention group
Group type: EXPERIMENTAL
Intervention: Residual insecticide treatment (RIT)
Number of subjects: 15750
Study 29117180 — intervention group
Group type: EXPERIMENTAL
Intervention: Insecticide-treated curtains (ITC)
Number of subjects: 15750
Study 29117180 — intervention group
Group type: COMPARATOR
Intervention: Routine Aedes control activities (control group)
Number of subjects: 15750
Study 25625810 — intervention group
Group type: EXPERIMENTAL
Intervention: Simultaneous intervention (F/V+, Sed-, PA+)
Number of subjects: 250
Study 25625810 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential intervention (F/V+, Sed- first, then PA+)
Number of subjects: 250
Study 25625810 — intervention group
Group type: COMPARATOR
Intervention: Stress Management Control
Number of subjects: 250
Study 22832419 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Power Strength Group (HPSG)
Number of subjects: 63
Study 22832419 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional Strength Group (FSG)
Number of subjects: 63
Study 22832419 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 63
Study 21876043 — intervention group
Group type: EXPERIMENTAL
Intervention: Voriconazole plus fluconazole
Number of subjects: 10
Study 21876043 — intervention group
Group type: COMPARATOR
Intervention: Voriconazole only
Number of subjects: 10
Study 21876043 — intervention group
Group type: EXPERIMENTAL
Intervention: Voriconazole after fluconazole
Number of subjects: 10
Study 18325770 — intervention group
Group type: EXPERIMENTAL
Intervention: Posterior cruciate-substituting (PS) TKA
Number of subjects: 192
Study 18325770 — intervention group
Group type: COMPARATOR
Intervention: Posterior cruciate-retaining (CR) TKA
Number of subjects: 192
Study 16844891 — intervention group
Group type: EXPERIMENTAL
Intervention: Medication-randomized clinical trial scenario
Number of subjects: 99
Study 16844891 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurosurgical clinical trial scenario
Number of subjects: 99
Study 12911356 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-use bougie
Number of subjects: 32
Study 12911356 — intervention group
Group type: COMPARATOR
Intervention: Multiple-use bougie
Number of subjects: 32
Study 10831902 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunotoxin MDX‐RA (low dose: 50 units)
Number of subjects: 26
Study 10831902 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunotoxin MDX‐RA (high dose: 100 units)
Number of subjects: 26
Study 10831902 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 9393916 — intervention group
Group type: EXPERIMENTAL
Intervention: Flexible intramedullary nailing (FIN)
Number of subjects: 19
Study 9393916 — intervention group
Group type: COMPARATOR
Intervention: External fixation (EF)
Number of subjects: 19
Study 7894066 — intervention group
Group type: EXPERIMENTAL
Intervention: History of hypertension
Number of subjects: 62
Study 7894066 — intervention group
Group type: EXPERIMENTAL
Intervention: Interruption of hypertension therapy
Number of subjects: 62
Study 7894066 — intervention group
Group type: EXPERIMENTAL
Intervention: Family history of stroke
Number of subjects: 62
Study 7894066 — intervention group
Group type: EXPERIMENTAL
Intervention: Long working hours
Number of subjects: 62
Study 7894066 — intervention group
Group type: EXPERIMENTAL
Intervention: Overwork
Number of subjects: 62
Study 7894066 — intervention group
Group type: EXPERIMENTAL
Intervention: Difficulty of taking a day-off each week
Number of subjects: 62
Study 7894066 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking
Number of subjects: 62
Study 7894066 — intervention group
Group type: EXPERIMENTAL
Intervention: Preference for salty taste
Number of subjects: 62
Study 7894066 — intervention group
Group type: EXPERIMENTAL
Intervention: Habitual drinking
Number of subjects: 62
Study 7894066 — intervention group
Group type: EXPERIMENTAL
Intervention: High blood pressure (from mass health examination data)
Number of subjects: 62
Study 7894066 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum cholesterol (from mass health examination data)
Number of subjects: 62
Study 3128589 — intervention group
Group type: EXPERIMENTAL
Intervention: Cromolyn sodium by MDI (1 mg per actuation)
Number of subjects: 155
Study 3128589 — intervention group
Group type: COMPARATOR
Intervention: Placebo by MDI
Number of subjects: 155
Study 31007059 — intervention group
Group type: EXPERIMENTAL
Intervention: Muscle Cramp Scale (MCS)
Number of subjects: 56
Study 31007059 — intervention group
Group type: COMPARATOR
Intervention: Muscle Cramp Scale (MCS) and cramp diary
Number of subjects: 56
Study 27704296 — intervention group
Group type: EXPERIMENTAL
Intervention: aPDT (low power laser: 660 nm, 40 mW, 90 J/cm2, methylene blue 0.01%) performed at baseline and 3, 6, and 9 months
Number of subjects: 28
Study 27704296 — intervention group
Group type: COMPARATOR
Intervention: Control group (details not specified)
Number of subjects: 28
Study 27986741 — intervention group
Group type: EXPERIMENTAL
Intervention: CBM‐I with prior RNT
Number of subjects: 120
Study 27986741 — intervention group
Group type: EXPERIMENTAL
Intervention: CBM‐I without prior RNT (standard CBM‐I)
Number of subjects: 120
Study 27986741 — intervention group
Group type: COMPARATOR
Intervention: Active control (no resolution of ambiguity)
Number of subjects: 120
Study 24643920 — intervention group
Group type: EXPERIMENTAL
Intervention: Desflurane (group D, n = 32)
Number of subjects: 60
Study 24643920 — intervention group
Group type: COMPARATOR
Intervention: Propofol (group P, n = 28)
Number of subjects: 60
Study 24643920 — intervention group
Group type: EXPERIMENTAL
Intervention: Desflurane (group D)
Number of subjects: 60
Study 24643920 — intervention group
Group type: COMPARATOR
Intervention: Propofol (group P)
Number of subjects: 60
Study 22002175 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone (50 or 200 mg/day)
Number of subjects: 29
Study 22002175 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study 19224159 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional therapy plus intravenous supplementation with omega‐3 fish oil emulsion 0.2 g/kg every day (FO group)
Number of subjects: 60
Study 19224159 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional therapy plus intravenous supplementation with omega‐3 fish oil emulsion (FO group)
Number of subjects: 60
Study 17300356 — intervention group
Group type: EXPERIMENTAL
Intervention: Topiramate 100 mg/day
Number of subjects: 306
Study 17300356 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 306
Study 15149252 — intervention group
Group type: EXPERIMENTAL
Intervention: Depressed participants
Number of subjects: 0
Study 15149252 — intervention group
Group type: EXPERIMENTAL
Intervention: Older adults
Number of subjects: 0
Study 15149252 — intervention group
Group type: COMPARATOR
Intervention: Nondepressed control participants
Number of subjects: 0
Study 15149252 — intervention group
Group type: COMPARATOR
Intervention: Depressed participants vs. older participants
Number of subjects: 0
Study 12149668 — intervention group
Group type: EXPERIMENTAL
Intervention: Lercanidipine tablets 10 mg once-daily (n = 234)
Number of subjects: 465
Study 12149668 — intervention group
Group type: COMPARATOR
Intervention: Losartan tablets 50 mg once-daily (n = 231)
Number of subjects: 465
Study 9862408 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine nasal spray (1 mg)
Number of subjects: 91
Study 9862408 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine gum (4 mg)
Number of subjects: 91
Study 9862408 — intervention group
Group type: COMPARATOR
Intervention: Saline placebo nasal spray
Number of subjects: 91
Study 9862408 — intervention group
Group type: COMPARATOR
Intervention: Placebo gum
Number of subjects: 91
Study 9862408 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine nasal spray and nicotine gum
Number of subjects: 91
Study 8548940 — intervention group
Group type: COMPARATOR
Intervention: rhGH (0.0675 IU/kg, 3 times/week)
Number of subjects: 21
Study 8548940 — intervention group
Group type: EXPERIMENTAL
Intervention: Pamidronate
Number of subjects: 21
Study 8548940 — intervention group
Group type: EXPERIMENTAL
Intervention: rhGH + Pamidronate
Number of subjects: 21
Study 8548940 — intervention group
Group type: EXPERIMENTAL
Intervention: rhGH
Number of subjects: 21
Study 2167109 — intervention group
Group type: EXPERIMENTAL
Intervention: Total hip replacement surgery
Number of subjects: 122
Study 2167109 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombi location analysis
Number of subjects: 122
Study 2167109 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombus characteristics
Number of subjects: 122
Study 2167109 — intervention group
Group type: EXPERIMENTAL
Intervention: Types of thrombosis
Number of subjects: 122
Study 320856 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E (1,600 I.U. of d-alpha-tocopherol succinate daily) for 6 months
Number of subjects: 48